Salicylhydroxamic acid inhibits myeloperoxidase activity

M. Ikeda-Saito, D. A. Shelley, L. Lu, K. S. Booth, W. S. Caughey, S. Kimura

Research output: Contribution to journalArticlepeer-review

54 Citations (Scopus)


Salicylhydroxamic and benzohydroxamic acids were found to bind to the resting state of myeloperoxidase and inhibit ligand binding to the heme iron. An ionizable group on the enzyme with pK(a) = 4 affects salicylhydroxamic acid binding; binding occurs when this group is not protonated. The binding of the heme iron ligands (e.g. cyanide, nitrite, and chloride) is probably controlled by the same ionizable group. The equilibrium dissociation constant of the salicylhydroxamic acid-myeloperoxidase complex is about 2 x 10-6 M, and the association rate constant is 7.4 x 106 M-1·s-1. Salicylhydroxamic acid serves as a donor to the higher oxidation state of myeloperoxidase and thereby inhibits guaiacol oxidation. Salicylhydroxamic acid was also found to bind to intestinal peroxidase and lactoperoxidase. Salicylhydroxamic acid binding to all three mammalian peroxidases was about 3 orders of magnitude stronger than benzohydroxamic acid binding. We conclude that the salicylhydroxamic and benzohydroxamic acids bind in the distal heme cavity of these peroxidases and interact with the heme ligand binding site.

Original languageEnglish
Pages (from-to)3611-3616
Number of pages6
JournalJournal of Biological Chemistry
Issue number6
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Salicylhydroxamic acid inhibits myeloperoxidase activity'. Together they form a unique fingerprint.

Cite this